Efficacy and Safety of Cream containing Dipotassium Glycyrrhizinate, Vaccinium Myrtillius, Epigallocatechin Gallatyl Glucoside, Tamarindus Indica Compared with Triamcinolone acetonide Cream in the treatment of eczema and plaque psoriasis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20211025002

Enrollment

Registered

2021-10-25

Start date

2019-03-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Efficacy and Safety of Cream containing Dipotassium Glycyrrhizinate, Vaccinium Myrtillius, Epigallocatechin Gallatyl Glucoside, Tamarindus Indica Compared with Triamcinolone acetonide Cream in the treatment of eczema and plaque psoriasis Eczema, Plaque type psoriasis, 0.1% Triamcinolone acetonide , Dipotassium glycyrrhizinate acid, Vaccinium Myrtillius, Epigallocatechin Gallatyl Glucoside, Tamarindus Indica

Interventions

Cream containing Dipotassium Glycyrrhizinate, Vaccinium Myrtillius, Epigallocatechin Gallatyl Glucoside, Tamarindus Indica twice daily for 1 month,TA cream twice daily for 1 month

Active Comparator Drug,Active Comparator Drug

Cream containing Dipotassium Glycyrrhizinate, Vaccinium Myrtillius, Epigallocatechin Gallatyl Glucoside, Tamarindus Indica,TA cream

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The participants had both sided of eczema or plaque psoriasis with approximately similar severity 2. Older than 18 years

Exclusion criteria

Exclusion criteria: 1. Topical steroid used in the recent 2 weeks 2. Systemic immunosuppressive drugs used in the recent 4 weeks 3. Pregnancy/lactation 4. History of allergic reaction following study cream

Design outcomes

Primary

Measure	Time frame
efficacy and safety 1 month pEASI and pPASI	—

Secondary

Measure	Time frame
improve of skin barrier function 1 month Transepidermal water loss/skin hydration/DLQI/ clinician assessment	—

Countries

Thailand

Contacts

Public ContactSiriwan Palawisuth

Punyananthaphikkhu Chonprathan Medical Center

siriwan_monk@yahoo.com025022345

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026